Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

被引：0
|
作者：
Majd Issa
Brett G. Klamer
Nikol Mladkova
Georgios I. Laliotis
Vidhya Karivedu
Priyanka Bhateja
Chase Byington
Khaled Dibs
Xueliang Pan
Arnab Chakravarti
John Grecula
Sachin R. Jhawar
Darrion Mitchell
Sujith Baliga
Matthew Old
Ricardo L. Carrau
James W. Rocco
Dukagjin M. Blakaj
Marcelo Bonomi
机构：
[1] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Medical Oncology
[2] The Ohio State University,Center for Biostatistics, Department of Biomedical Informatics
[3] The Ohio State University Wexner Medical Center,Division of Radiation Oncology
[4] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center and Department of Oncology
[5] The Ohio State University Wexner Medical Center,Department of Otolaryngology
来源：
BMC Cancer | / 22卷
关键词：
Head and neck cancer; Head and neck squamous cell carcinoma; Immunotherpay; Immune checkpoint inhibitors; Survival in head and neck cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical predictors for survival with the addition of chemotherapy in patients with recurrent-metastatic squamous cell carcinoma of the head and neck after progression on immune checkpoint inhibitors
    Issa, M.
    Klamer, B.
    Bhateja, P.
    Karivedu, V.
    Laliotis, G.
    Dibs, K.
    Mladkova, N.
    Pan, X.
    Old, M.
    Gamez, M.
    Grecula, J.
    Jhawar, S.
    Mitchell, D.
    Baliga, S.
    Carrau, R.
    Rocco, J.
    Bonomi, M.
    Blakaj, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S797 - S798
  • [42] Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
    Nishikawa, Daisuke
    Suzuki, Hidenori
    Beppu, Shintaro
    Terada, Hoshino
    Sawabe, Michi
    Kadowaki, Shigenori
    Sone, Michihiko
    Hanai, Nobuhiro
    CANCER SCIENCE, 2021, 112 (01) : 339 - 346
  • [43] A radiomics based prognostic model for patients with head and neck squamous cell carcinoma
    Keek, S.
    Wesseling, F.
    Woodruff, H.
    van Timmeren, J.
    Nauta, I.
    Hoffmann, T.
    Cavalieri, S.
    Calareso, G.
    Primakov, S.
    Leijenaar, R.
    Licitra, L.
    Ravanelli, M.
    Scheckenbach, K.
    Poli, T.
    Lanfranco, D.
    Vergeer, M.
    Leemans, R.
    Brakenhoff, R.
    Hoebers, F.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S509 - S510
  • [44] The prognostic impact of the immune signature in head and neck squamous cell carcinoma
    Baysal, Hasan
    Siozopoulou, Vasiliki
    Zaryouh, Hannah
    Hermans, Christophe
    Lau, Ho Wa
    Lambrechts, Hilde
    Fransen, Erik
    De Pauw, Ines
    Jacobs, Julie
    Peeters, Marc
    Pauwels, Patrick
    Vermorken, Jan Baptist
    Smits, Evelien
    Lardon, Filip
    De Waele, Jorrit
    Wouters, An
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste-Rotllan, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada-Bouzid, Esma
    Even, Caroline
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 123 - 129
  • [46] Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Economopoulou, Panagiota
    Anastasiou, Maria
    Papaxoinis, George
    Spathas, Nikolaos
    Spathis, Aris
    Oikonomopoulos, Nikolaos
    Kotsantis, Ioannis
    Tsavaris, Onoufrios
    Gkotzamanidou, Maria
    Gavrielatou, Niki
    Vagia, Elena
    Kyrodimos, Efthymios
    Gagari, Eleni
    Giotakis, Evangelos
    Delides, Alexander
    Psyrri, Amanda
    CANCERS, 2021, 13 (02) : 1 - 15
  • [47] Cerebral Infarction as a Rare Adverse Event of Immune Checkpoint Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma: A Case Series
    Inoue, Takahiro
    Kumai, Takumi
    Ohara, Kenzo
    Takahara, Miki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [48] Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Recurrent/Metastatic Squamous Cell Carcinomas of the Head and Neck Previously Treated with Immune Checkpoint Inhibitors
    Rodriguez, C. P.
    Fromm, J.
    Liao, J. J.
    Laramore, G. E.
    Lo, S. S.
    Goff, P. H.
    Santana-Davila, R.
    Martins, R. G.
    Futran, N.
    Houlton, J.
    Barber, B.
    Parvathaneni, U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E282 - E283
  • [49] On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy
    Nenclares, Pablo
    Gunn, Lucinda
    Soliman, Heba
    Bover, Mateo
    Trinh, Amy
    Leslie, Isla
    Wong, Kee Howe
    Melcher, Alan
    Newbold, Kate
    Nutting, Chris M.
    Ap Dafydd, Derfel
    Bhide, Shreerang A.
    Harrington, Kevin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [50] A Six-Gene-Based Prognostic Model Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients
    Shrikant Pawar
    Aditya Stanam
    Journal of Maxillofacial and Oral Surgery, 2019, 18 : 320 - 327
12345